Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven J Frank

Showing results (101-110 of 383) with videos related to

Pageof 39
Sort By:
Chinese Clinical Oncology|August 11, 2016
Reduced acute toxicity and improved efficacy from intensity-modulated proton therapy (IMPT) for the management of head and neck cancerMatthew R McKeever, Terence T Sio, G Brandon Gunn, et al.
Brachytherapy|June 26, 2012
Knife or needles? A cohort analysis of outcomes after radical prostatectomy or brachytherapy for men with low- or intermediate-risk adenocarcinoma of the prostateChristine M Fisher, Patricia Troncoso, David A Swanson, et al.
Brachytherapy|April 27, 2017
Prostate brachytherapy, either alone or in combination with external beam radiation, is associated with longer overall survival in men with favorable pathologic Group 4 (Gleason score 8) prostate cancerMatthew W Jackson, Arya Amini, Bernard L Jones, et al.
Ophthalmic Plastic and Reconstructive Surgery|May 21, 2014
Correlation of American Joint Committee on Cancer T category for eyelid carcinoma with outcomes in patients with periocular Merkel cell carcinomaMatthew C Sniegowski, Carla L Warneke, William H Morrison, et al.
Physics in Medicine and Biology|September 6, 2024
Deep learning-based statistical robustness evaluation of intensity-modulated proton therapy for head and neck cancerDanfu Liang, Ivan Vazquez, Mary P Gronberg, et al.
Journal of Contemporary Brachytherapy|August 10, 2016
Development of a magnetic resonance imaging protocol to visualize encapsulated contrast agent markers in prostate brachytherapy recipients: initial patient experienceTze Yee Lim, Rajat J Kudchadker, Jihong Wang, et al.
Cancer|June 10, 2011
Outcomes of malignant tumors of the lacrimal apparatus: the University of Texas MD Anderson Cancer Center experienceHeath D Skinner, Adam S Garden, David I Rosenthal, et al.
Annals of Surgical Oncology|February 1, 2015
Risk Factors and Prognosis for Myoepithelial Carcinoma of the Major Salivary GlandsYu-Xiong Su, Dianna B Roberts, Ehab Y Hanna, et al.
Brachytherapy|February 6, 2013
Improving prostate brachytherapy quality assurance with MRI-CT fusion-based sector analysis in a phase II prospective trial of men with intermediate-risk prostate cancerAaron P Brown, Thomas J Pugh, David A Swanson, et al.
Cancer Journal (Sudbury, Mass.)|March 25, 2026
Radiobiology of Particle Therapy: Revisiting the Preclinical Knowledge Base on Helium Ion TherapyLi Wang, Aron Popovtzer, Albert C Koong, et al.
Pageof 39

Showing results (101-110 of 383) with videos related to

Sort By:
Pageof 39
Chinese Clinical Oncology|August 11, 2016
Reduced acute toxicity and improved efficacy from intensity-modulated proton therapy (IMPT) for the management of head and neck cancerMatthew R McKeever, Terence T Sio, G Brandon Gunn, et al.
Brachytherapy|June 26, 2012
Knife or needles? A cohort analysis of outcomes after radical prostatectomy or brachytherapy for men with low- or intermediate-risk adenocarcinoma of the prostateChristine M Fisher, Patricia Troncoso, David A Swanson, et al.
Brachytherapy|April 27, 2017
Prostate brachytherapy, either alone or in combination with external beam radiation, is associated with longer overall survival in men with favorable pathologic Group 4 (Gleason score 8) prostate cancerMatthew W Jackson, Arya Amini, Bernard L Jones, et al.
Ophthalmic Plastic and Reconstructive Surgery|May 21, 2014
Correlation of American Joint Committee on Cancer T category for eyelid carcinoma with outcomes in patients with periocular Merkel cell carcinomaMatthew C Sniegowski, Carla L Warneke, William H Morrison, et al.
Physics in Medicine and Biology|September 6, 2024
Deep learning-based statistical robustness evaluation of intensity-modulated proton therapy for head and neck cancerDanfu Liang, Ivan Vazquez, Mary P Gronberg, et al.
Journal of Contemporary Brachytherapy|August 10, 2016
Development of a magnetic resonance imaging protocol to visualize encapsulated contrast agent markers in prostate brachytherapy recipients: initial patient experienceTze Yee Lim, Rajat J Kudchadker, Jihong Wang, et al.
Cancer|June 10, 2011
Outcomes of malignant tumors of the lacrimal apparatus: the University of Texas MD Anderson Cancer Center experienceHeath D Skinner, Adam S Garden, David I Rosenthal, et al.
Annals of Surgical Oncology|February 1, 2015
Risk Factors and Prognosis for Myoepithelial Carcinoma of the Major Salivary GlandsYu-Xiong Su, Dianna B Roberts, Ehab Y Hanna, et al.
Brachytherapy|February 6, 2013
Improving prostate brachytherapy quality assurance with MRI-CT fusion-based sector analysis in a phase II prospective trial of men with intermediate-risk prostate cancerAaron P Brown, Thomas J Pugh, David A Swanson, et al.
Cancer Journal (Sudbury, Mass.)|March 25, 2026
Radiobiology of Particle Therapy: Revisiting the Preclinical Knowledge Base on Helium Ion TherapyLi Wang, Aron Popovtzer, Albert C Koong, et al.
Pageof 39